Benitec Biopharma Inc.

11.75
-0.67 (-5.39%)
At close: Mar 04, 2025, 9:45 AM

Benitec Biopharma Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13
Net Income -21.75M -19.56M -18.21M -13.88M -8.27M 2.61M -8.55M -4.37M -18.5M -8.83M -10.84M -6.42M
Depreciation & Amortization 343K 381K 392K 424K 374K 158K n/a 217K n/a n/a n/a n/a
Stock-Based Compensation 830K 452K 870K 634K 237K 957.2K n/a 386K n/a n/a n/a n/a
Other Working Capital 233K 714K 1.04M 8K 126K -24K n/a 760K n/a n/a n/a n/a
Other Non-Cash Items 1K 717K 10K -16K 2K 700K n/a -4.47M -1.7M -864.59K 1.14M -2.85M
Deferred Income Tax n/a -714K n/a n/a n/a -957.2K n/a -819.52K n/a n/a n/a n/a
Change in Working Capital 1.17M 714K 1.04M 8K 126K 1.32M n/a 760K n/a n/a n/a n/a
Operating Cash Flow -19.4M -18.01M -15.9M -12.83M -7.54M 4.79M -8.55M -8.3M -20.21M -9.69M -9.69M -9.27M
Capital Expenditures -179K -1K -13K -221K -95K -403.4K -60.97K -131.41K -255.4K -387.34K -475.46K -29.2K
Acquisitions n/a n/a n/a n/a 1K 4K n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a -131K n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a -0.00 202.03 -47.01K 30.33K n/a n/a n/a n/a
Investing Cash Flow -179K -1K -13K -221K -94K -399.19K -107.99K -232.07K -255.4K -387.34K -475.46K -29.2K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -5.89M -1.87M n/a -3.23M -480K -688.11K -229.93K 1.74M 2.98M -255.41K -313.52K n/a
Financial Cash Flow 68.03M 16.02M n/a 22.52M 1.77M -688.11K 6.25M 6.1M 17.51M 39.88K 48.96K 35.66M
Net Cash Flow 48.44M -1.59M -15.71M 9.97M -5.92M 4.43M -947.62K -657.02K -2.66M -7.34M -9.01M 27.17M
Free Cash Flow -19.58M -18.01M -15.91M -13.05M -7.63M 4.39M -8.61M -8.44M -20.46M -10.08M -10.17M -9.3M